uniQure (QURE) Non-Current Assets (2015 - 2026)
uniQure's (QURE) quarterly Non-Current Assets came in at $163.0 million in Q1 2026, down 4.13% year-on-year from $170.0 million in Q1 2025, and down 3.53% quarter-over-quarter from $168.9 million in Q4 2025.
uniQure (QURE) Non-Current Assets (2015 - 2026) Analysis & Trends
uniQure's Non-Current Assets history runs 12 years deep, the most recent figure standing at $163.0 million for Q1 2026.
- On a quarterly basis, Non-Current Assets fell 4.13% year-over-year to $163.0 million in Q1 2026; TTM through Mar 2026 was $163.0 million, a 4.13% decrease from a year earlier, with the FY2025 full-year figure at $168.9 million, up 1.61% from the prior year.
- Non-Current Assets fell to $163.0 million in Q1 2026 per QURE's latest filing, from $168.9 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $228.2 million in Q4 2022 and bottomed at $138.9 million in Q2 2024.
- The 5-year median for Non-Current Assets is $176.3 million (2025), against an average of $176.6 million.
- Across the five-year window, Non-Current Assets jumped 119.49% in 2022 and declined 25.26% in 2024, its largest moves.
- Year by year, Non-Current Assets stood at $228.2 million in 2022, then fell by 21.19% to $179.8 million in 2023, then slipped by 7.56% to $166.2 million in 2024, then climbed by 1.61% to $168.9 million in 2025, then fell by 3.53% to $163.0 million in 2026.
- Per Business Quant, the three latest QURE Non-Current Assets figures stand at $163.0 million (Q1 2026), $168.9 million (Q4 2025), and $172.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 21.65 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 5.83 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.95 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 3.95 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.66 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.96 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 285.82 Mn |
| 10 | uniQure | 2.47 Bn | 2.47 Bn | 3.34 Mn | 162.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 162.96 Mn |
| Dec 31, 2025 | 168.92 Mn |
| Sep 30, 2025 | 172.19 Mn |
| Jun 30, 2025 | 176.32 Mn |
| Mar 31, 2025 | 169.98 Mn |
| Dec 31, 2024 | 166.25 Mn |
| Sep 30, 2024 | 181.67 Mn |
| Jun 30, 2024 | 138.88 Mn |
| Mar 31, 2024 | 174.05 Mn |
| Dec 31, 2023 | 179.84 Mn |
| Sep 30, 2023 | 177.92 Mn |
| Jun 30, 2023 | 185.81 Mn |
| Mar 31, 2023 | 188.36 Mn |
| Dec 31, 2022 | 228.19 Mn |
| Sep 30, 2022 | 173.66 Mn |
| Jun 30, 2022 | 177.91 Mn |
| Mar 31, 2022 | 178.94 Mn |
| Dec 31, 2021 | 180.94 Mn |
| Sep 30, 2021 | 180.86 Mn |
| Jun 30, 2021 | 90.04 Mn |